The trading price of Journey Medical Corp (NASDAQ:DERM) closed lower on Friday, January 17, and closing at $3.66, -3.43% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $3.65 and $3.99. In examining the 52-week price action we see that the stock hit a 52-week high of $6.89 and a 52-week low of $2.85. Over the past month, the stock has lost -25.46% in value.
Journey Medical Corp, whose market valuation is $76.46 million at the time of this writing, is expected to release its quarterly earnings report in February. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0 per share this quarter, however they have predicted annual earnings per share of 0 for current year and 0 for next year.
Analysts have forecast the company to bring in revenue of 14.21M for the current quarter, with the likely lows of 13.26M and highs of 14.8M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 56.72M.
On the technical side, indicators suggest DERM has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 75% Sell, while an average of long term indicators suggests that the stock is currently 50% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned DERM a recommendation rating is 1. Out of them, 0 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Journey Medical Corp (DERM) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that DERM’s price is currently -11.64% off the SMA20 and -24.90% off the SMA50. The RSI metric on the 14-day chart is currently showing 29.47, and weekly volatility stands at 7.80%. When measured over the past 30 days, the indicator reaches 7.99%. Journey Medical Corp (NASDAQ:DERM)’s beta value is currently sitting at 1.01, while the Average True Range indicator is currently displaying 0.33.
To see how Journey Medical Corp stock has been performing in comparison to its peers in the industry, here are the numbers: DERM stock’s performance was -3.43% in the latest trading, and -28.38% in the past year.
An evaluation of the daily trading volume of Journey Medical Corp (NASDAQ:DERM) indicates that the 3-month average is 110.02K. However, this figure has increased over the past 10 days to an average of 59210.0.
Currently, records show that 14.73 million of the company’s shares remain outstanding. The insiders hold 51.16% of outstanding shares, whereas institutions hold 17.63%. The stats also highlight that short interest as of 2024-12-31, stood at 76766.0 shares, resulting in a short ratio of 0.77 at that time. From this, we can conclude that short interest is 171.00 of the company’s total outstanding shares. It is noteworthy that short shares in December were up slightly from the previous month’s figure, which was 76739.0. However, since the stock’s price has seen -6.39% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
